Post-approval studies (Phase 4)WithdrawnNCT02121288
What this trial is testing
Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease Patients
Who this might be right for
Peripheral Artery DiseaseVascular DiseaseArterial Occlusion Disease+2 more
AstraZeneca